Current Price and Market Context
As of 11 June 2026, Krsnaa Diagnostics is trading at ₹535.35, down 1.66% from the previous close of ₹544.40. The stock’s intraday range has been relatively narrow, with a high of ₹550.00 and a low of ₹533.65. Over the past 52 weeks, the share price has fluctuated between ₹502.20 and ₹891.80, reflecting significant volatility and a downward trajectory in recent months.
Technical Trend and Momentum Analysis
The technical trend for Krsnaa Diagnostics has shifted from mildly bearish to outright bearish, signalling increased selling pressure. The Moving Average Convergence Divergence (MACD) indicator presents a bearish stance on the weekly chart and a mildly bearish outlook on the monthly timeframe, indicating that momentum is weakening but not yet at an extreme level.
The Relative Strength Index (RSI), a momentum oscillator, currently shows no clear signal on both weekly and monthly charts, suggesting that the stock is neither oversold nor overbought. This neutral RSI reading implies that the stock could be poised for further directional movement depending on other technical factors.
Bollinger Bands, which measure volatility and price levels relative to moving averages, are bearish on both weekly and monthly charts. This suggests that the stock price is trending towards the lower band, indicating increased downside risk and potential continuation of the current downtrend.
Moving Averages and Other Indicators
Daily moving averages reinforce the bearish outlook, with the stock price trading below key averages, signalling a lack of upward momentum. The Know Sure Thing (KST) indicator presents a mildly bullish signal on the weekly chart but turns bearish on the monthly scale, reflecting short-term attempts at recovery overshadowed by longer-term weakness.
Dow Theory assessments align with this mixed picture, showing a mildly bearish weekly trend but a mildly bullish monthly trend, highlighting the stock’s struggle to establish a sustained directional move. On-Balance Volume (OBV) readings show no clear trend on either weekly or monthly charts, indicating that volume is not confirming price movements and adding to the uncertainty.
Comparative Performance Versus Sensex
When compared to the benchmark Sensex, Krsnaa Diagnostics has underperformed significantly across multiple timeframes. Over the past week, the stock declined by 0.85%, slightly worse than the Sensex’s 0.49% fall. The one-month return shows a steep drop of 10.92% against the Sensex’s 4.33% decline. Year-to-date, the stock has plummeted 25.68%, nearly double the Sensex’s 13.19% fall.
Over the last year, Krsnaa Diagnostics has lost 22.97%, while the Sensex gained 10.21%. Even over a three-year horizon, the stock has declined 6.6%, contrasting sharply with the Sensex’s 18.14% gain. This persistent underperformance highlights the challenges faced by the company amid sectoral and market headwinds.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Mojo Score and Ratings Update
Krsnaa Diagnostics currently holds a Mojo Score of 40.0, categorised as a Sell rating. This represents an upgrade from a previous Strong Sell grade assigned on 6 February 2026, reflecting a slight improvement in technical and fundamental outlooks. Despite this upgrade, the overall sentiment remains cautious given the prevailing bearish technical indicators and the company’s small-cap status, which often entails higher volatility and risk.
Technical Indicators in Detail
The weekly MACD’s bearish signal suggests that the short-term momentum is weakening, with the MACD line likely below the signal line, indicating selling pressure. The monthly MACD’s mildly bearish stance implies that while the longer-term trend is negative, it is not yet decisively so, leaving room for potential recovery if positive catalysts emerge.
The absence of RSI signals on both weekly and monthly charts points to a neutral momentum environment. This could mean the stock is consolidating or preparing for a directional breakout, but current price action favours the downside given other bearish signals.
Bollinger Bands’ bearish readings on both timeframes indicate that the stock price is gravitating towards the lower band, often a sign of increased volatility and potential continuation of the downtrend. Investors should watch for any price moves outside the bands, which could signal a reversal or acceleration of the trend.
Moving Averages and KST Insights
Daily moving averages being bearish confirms that the stock is trading below its short- and medium-term averages, a classic sign of downward momentum. The KST indicator’s mildly bullish weekly signal suggests some short-term buying interest, but the monthly bearish reading tempers optimism, signalling that longer-term momentum remains weak.
Dow Theory’s mixed signals further complicate the outlook. The mildly bearish weekly trend indicates short-term weakness, while the mildly bullish monthly trend hints at a possible longer-term base formation or recovery phase. However, without confirmation from volume trends—OBV shows no clear direction—these signals remain tentative.
Krsnaa Diagnostics Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaway and Outlook
Investors in Krsnaa Diagnostics should approach the stock with caution given the prevailing bearish technical signals and the company’s underperformance relative to the broader market. The downgrade from Strong Sell to Sell reflects a modest improvement but does not yet signal a turnaround. The technical indicators collectively suggest that the stock remains in a downtrend, with limited signs of immediate recovery.
However, the mildly bullish signals on some weekly indicators and the mixed Dow Theory readings imply that the stock could be forming a base for a potential rebound if supported by positive fundamental developments or sectoral tailwinds. Close monitoring of volume trends and price action around key moving averages will be crucial for identifying any shift in momentum.
Given the small-cap nature of Krsnaa Diagnostics and its volatile price history, investors should weigh the risks carefully and consider diversification or alternative opportunities within the Healthcare Services sector.
Summary of Key Technical Metrics:
- Current Price: ₹535.35 (down 1.66%)
- 52-Week Range: ₹502.20 - ₹891.80
- MACD: Weekly Bearish, Monthly Mildly Bearish
- RSI: Neutral (No Signal) on Weekly and Monthly
- Bollinger Bands: Bearish on Weekly and Monthly
- Moving Averages: Daily Bearish
- KST: Weekly Mildly Bullish, Monthly Bearish
- Dow Theory: Weekly Mildly Bearish, Monthly Mildly Bullish
- OBV: No Clear Trend
- Mojo Score: 40.0 (Sell, upgraded from Strong Sell)
In conclusion, while Krsnaa Diagnostics shows some tentative signs of stabilisation, the overall technical momentum remains negative. Investors should remain vigilant and consider the broader market context and sector dynamics before making investment decisions.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
